Virgil Thompson
Plus aucun poste en cours
Profil
Virgil D.
Thompson served as President, CEO, and Director at various pharmaceutical companies including Splash Pharmaceuticals, Cytel Corp., Chimeric Therapies, Cibus Pharmaceuticals, Questcor Pharmaceuticals, and Savient Pharmaceuticals.
He also served as Chairman at Questcor Pharmaceuticals and Spinnaker Biosciences, and as an Independent Director at Soligenix, Aradigm Corp., GenZ Corp., and Processa Pharmaceuticals.
Thompson was also a Director at Mallinckrodt Plc and Promet Therapeutics LLC.
Prior to his work in the pharmaceutical industry, Thompson served as President of Syntex Laboratories, Inc. and as COO of Syntex Corp.
Thompson received his undergraduate degree from the University of Kansas and his graduate degree from George Washington University Law School.
Anciens postes connus de Virgil Thompson
Sociétés | Poste | Fin |
---|---|---|
Spinnaker Biosciences, Inc.
Spinnaker Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Spinnaker Biosciences, Inc. is a private company based in Solana Beach, CA that specializes in the development of technology for sustained/controlled release drug delivery using non-toxic, biocompatible, and biodegradable nanoporous silicon based microparticles and nanoparticles. The company's lead programs include a long-acting sustained release ranibizumab drug product for the treatment of neovascular age-related macular degeneration. | Directeur Général | 01/07/2015 |
PROCESSA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/11/2023 |
ARADIGM CORPORATION | Président | 01/07/2017 |
GenZ Corp.
GenZ Corp. Miscellaneous Commercial ServicesCommercial Services GenZ Corp. engages in the provision of commercial physical research services. The firm also develops agricultural spray technology for strawberries, row crops, multibar sprayer, vineyard sprayer, and sprayer services. The company was founded by Grant Thompson and is headquartered in Boise, ID. | Directeur/Membre du Conseil | 01/01/2017 |
QUESTCOR PHARMACEUTICALS INC | Président | 14/08/2014 |
Formation de Virgil Thompson
University of Kansas | Undergraduate Degree |
George Washington University Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
SOLIGENIX, INC. | Health Technology |
MALLINCKRODT PLC | Health Technology |
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 12 |
---|---|
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Syntex Corp. | Health Technology |
Aradigm Corp.
Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Splash Pharmaceuticals, Inc.
Splash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Splash Pharmaceuticals, Inc. manufactures and develops pharmaceutical products. It is engaged in the development of proprietary drugs that treat diseases involving cell migration, invasion and metastasis. The firm creates non-toxic cancer drugs which block angiogensis (blood supply) and metastasis (deadly spread) of different types of solid tumor. The company was founded by Terence R. Jones on December 13, 2001 and is headquartered in Solana Beach, CA. | Health Technology |
GenZ Corp.
GenZ Corp. Miscellaneous Commercial ServicesCommercial Services GenZ Corp. engages in the provision of commercial physical research services. The firm also develops agricultural spray technology for strawberries, row crops, multibar sprayer, vineyard sprayer, and sprayer services. The company was founded by Grant Thompson and is headquartered in Boise, ID. | Commercial Services |
Syntex Laboratories, Inc. | |
Cytel Corp. | |
Chimeric Therapies, Inc. | |
Cibus Pharmaceuticals, Inc. | |
Spinnaker Biosciences, Inc.
Spinnaker Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Spinnaker Biosciences, Inc. is a private company based in Solana Beach, CA that specializes in the development of technology for sustained/controlled release drug delivery using non-toxic, biocompatible, and biodegradable nanoporous silicon based microparticles and nanoparticles. The company's lead programs include a long-acting sustained release ranibizumab drug product for the treatment of neovascular age-related macular degeneration. | Health Technology |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Health Technology |